NONOF
Price
$67.44
Change
-$0.06 (-0.09%)
Updated
May 21 closing price
Capitalization
305.18B
VRTX
Price
$434.00
Change
-$1.32 (-0.30%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
114.83B
70 days until earnings call
Interact to see
Advertisement

NONOF vs VRTX

Header iconNONOF vs VRTX Comparison
Open Charts NONOF vs VRTXBanner chart's image
Novo-Nordisk A/S
Price$67.44
Change-$0.06 (-0.09%)
Volume$42.13K
Capitalization305.18B
Vertex Pharmaceuticals
Price$434.00
Change-$1.32 (-0.30%)
Volume$38.52K
Capitalization114.83B
NONOF vs VRTX Comparison Chart
Loading...
NONOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NONOF vs. VRTX commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NONOF is a StrongBuy and VRTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (NONOF: $67.44 vs. VRTX: $435.32)
Brand notoriety: NONOF and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NONOF: 42% vs. VRTX: 75%
Market capitalization -- NONOF: $305.18B vs. VRTX: $114.83B
NONOF [@Biotechnology] is valued at $305.18B. VRTX’s [@Biotechnology] market capitalization is $114.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NONOF’s FA Score shows that 1 FA rating(s) are green whileVRTX’s FA Score has 2 green FA rating(s).

  • NONOF’s FA Score: 1 green, 4 red.
  • VRTX’s FA Score: 2 green, 3 red.
According to our system of comparison, VRTX is a better buy in the long-term than NONOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NONOF’s TA Score shows that 7 TA indicator(s) are bullish while VRTX’s TA Score has 5 bullish TA indicator(s).

  • NONOF’s TA Score: 7 bullish, 2 bearish.
  • VRTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NONOF is a better buy in the short-term than VRTX.

Price Growth

NONOF (@Biotechnology) experienced а +5.36% price change this week, while VRTX (@Biotechnology) price change was +3.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.02%. For the same industry, the average monthly price growth was +7.66%, and the average quarterly price growth was -1.31%.

Reported Earning Dates

VRTX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+5.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NONOF($305B) has a higher market cap than VRTX($115B). VRTX has higher P/E ratio than NONOF: VRTX (32.76) vs NONOF (19.08). VRTX YTD gains are higher at: 8.100 vs. NONOF (-21.487). NONOF has higher annual earnings (EBITDA): 147B vs. VRTX (-74.9M). NONOF has more cash in the bank: 41.6B vs. VRTX (6.2B). VRTX has less debt than NONOF: VRTX (1.65B) vs NONOF (119B). NONOF has higher revenues than VRTX: NONOF (303B) vs VRTX (11.1B).
NONOFVRTXNONOF / VRTX
Capitalization305B115B265%
EBITDA147B-74.9M-196,262%
Gain YTD-21.4878.100-265%
P/E Ratio19.0832.7658%
Revenue303B11.1B2,730%
Total Cash41.6B6.2B671%
Total Debt119B1.65B7,216%
FUNDAMENTALS RATINGS
NONOF vs VRTX: Fundamental Ratings
NONOF
VRTX
OUTLOOK RATING
1..100
1663
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
6730
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6260
P/E GROWTH RATING
1..100
9728
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NONOF's Valuation (24) in the null industry is somewhat better than the same rating for VRTX (77) in the Biotechnology industry. This means that NONOF’s stock grew somewhat faster than VRTX’s over the last 12 months.

VRTX's Profit vs Risk Rating (30) in the Biotechnology industry is somewhat better than the same rating for NONOF (67) in the null industry. This means that VRTX’s stock grew somewhat faster than NONOF’s over the last 12 months.

VRTX's SMR Rating (100) in the Biotechnology industry is in the same range as NONOF (100) in the null industry. This means that VRTX’s stock grew similarly to NONOF’s over the last 12 months.

VRTX's Price Growth Rating (60) in the Biotechnology industry is in the same range as NONOF (62) in the null industry. This means that VRTX’s stock grew similarly to NONOF’s over the last 12 months.

VRTX's P/E Growth Rating (28) in the Biotechnology industry is significantly better than the same rating for NONOF (97) in the null industry. This means that VRTX’s stock grew significantly faster than NONOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NONOFVRTX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
62%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
44%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
60%
Declines
ODDS (%)
Bearish Trend 9 days ago
59%
Bearish Trend 9 days ago
45%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 2 days ago
58%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 4 days ago
35%
View a ticker or compare two or three
Interact to see
Advertisement
NONOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TASCX18.78N/A
N/A
Third Avenue Small Cap Value Instl
ISTNX76.08N/A
N/A
Macquarie Science and Technology R6
CFWCX26.20N/A
N/A
Calvert Global Water C
CLEYX20.94N/A
N/A
Columbia Select Large Cap Equity Inst3
PAHUX7.05N/A
N/A
PGIM Jennison NextGeneration Glb Opps Z

NONOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NONOF has been closely correlated with NVO. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NONOF jumps, then NVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NONOF
1D Price
Change %
NONOF100%
-0.09%
NVO - NONOF
70%
Closely correlated
N/A
LABFF - NONOF
23%
Poorly correlated
N/A
IMRN - NONOF
22%
Poorly correlated
+2.48%
QSI - NONOF
21%
Poorly correlated
-12.20%
VRTX - NONOF
21%
Poorly correlated
-2.65%
More